4th Annual Stem Cell Research & Therapeutic Conference - Register by March 17 for a 10% Discount

If you can't view this page, please use this link: http://www.gtcbio.com/newsletter/SCIV-w.htm

Present a Poster!
Abstract Deadline: March 17, 2008

UPCOMING EVENTS

3rd Imaging in Pre-clinical & Clinical Drug Development
March 17-18, 2008
San Diego, CA
4th Stem Cell Research & Therapeutics
April 17-18, 2008
Boston, MA
Register by Mar. 17
for a 10% discount

3rd Protein Kinases in Drug Discovery
May 5-6, 2008
San Diego, CA
Register by April 5
for a 10% discount

3rd Assay Development & Screening Technologies
June 5-6, 2008
San Francisco, CA
Register by April 5
for a 20% discount

2nd Rediscovering Biomarkers: Detection, Development & Validation
July 10-11, 2008
Boston, MA
Register by May 10
for a 20% discount

4th Modern Drug Discovery and Development Summit
6 Full Tracks
3 Short Symposia
6 Study Sessions
Oct. 15-17, 2008
San Diego, CA

AttendONE additional GTCbio Conferenceof your choice for only $400 more. Click
here to sign up!

AttendALL 2008 GTCbio Conferencesfor only $3000.
Click here to sign up!

Dear Colleague,
The 4th International ConferenceApril 17-18, 2008 in Boston, MA brings together
leading experts to discuss novel data on the latest cutting-edge advancements
in the field of stem cell research. Discussions from prominent keynotes including
Massachusetts Senator Richard T. Moore and Dr. Rudolf Jaenisch, founding member
of the Whitehead Institute at MIT will highlight some of the key stem cell
research and legislative issues facing the industry in the coming years.
Attendance of this conference will grant you access to significant new developments
in the field, dedicated networking time to with major players, as well information
that will help you advance to the next phase of your work.

Don't miss this forum! Register by March 17, 2008 for a 10% DISCOUNT.

Keynote Speakers:

   Richard T. Moore
Senator
D-Massachusetts

       Rudolf Jaenisch, Ph.D.
Founding Member, Whitehead Institute;
Professor of Biology
MIT

Featured Speakers:

   Malcolm Moos, M.D.
Medical Officer, Division of Cellular & Gene Therapies
FDA      Samuel H. Wood, M.D.
CEO
Stemagen

SESSIONS:

•

Differentiation of Stem Cells
•

Epigenomics & Reprogramming of Stem Cells
•

Regenerative Medicine & Therapeutics
•

Stem Cell Imaging
•

Cancer Stem Cells
•

Stem Cell Applications in Drug Discovery
•

Regulatory Aspects & Funding Opportunities

Click here for a FULL AGENDA

PRESENTERS INCLUDE

Basem Abdallah, Odense University Hospital
Anne Bang, Novocell
Miriam Bibel, Novartis
Petter Björquist, Cellartis
Caifu Chen, Applied Biosystems
Yen Choo, Plasticell Limited
Dennis O. Clegg, UCSB
Eyleen Goh, Duke-NUS Graduate Medical School Singapore
Austin Gurney, OncoMed Pharma
Ulrich Hoffmueller, Epiontis
Rudolf Jaenisch, MIT
Jeffrey Janus, International Stem Cell Corporation
Christophe Labie, Sanofi Aventis
Edward Lanphier, Sangamo BioSciences
Jane S. Lebkowski, Geron Corp.
Jan Paul Medema, Universiteit Van Amsterdam
Huseyin Mehmet, Merck & Co.
Richard T. Moore, Senator, D-Massachusetts
Malcolm Moos, FDA
Jeffrey Norenberg, University of New Mexico Health Sciences Center
Jay Sharma, Celprogen
David Taylor, University of Central Florida
Mark Thiede, Pfizer, Inc.
Anthony Ting, Athersys
Bruce Wentworth, Genzyme
Michael West, BioTime
Samuel Wood, Stemagen
Nicholas Zavazava, University of Iowa

10% DISCOUNT DEADLINE: March 17, 2008

Who Should Attend:
- Stem Cell Scientists
- Business Development Managers
- Senior Executives
- CEOs
- Attorneys
- Regulatory body representatives
- Venture Capitalists
- Medical Doctors
- Government Officials
- Press and Media partners
Press representatives are welcome to attend and review the conference. For
press inquiries, contact Customer SerIf you can't view this page, please use this link: http://www.gtcbio.com/newsletter/SCIV-w.htm